Search

everythinglearnresearchcommunity

for

Search:↓

PCOS often causes skin issues like excess hair, acne, and hair loss, needing early treatment.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Metformin helps improve menstrual irregularities and some hormone levels in PCOS patients, but not symptoms like excess hair, acne, or hair loss.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

A vibrating anesthetic device significantly reduces pain during mesotherapy for hair loss without complications.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Correcting trace element imbalances may help reduce alopecia areata symptoms.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.